In October 2016, the owners of BioWorld – the Intellectual Property & Science business of Thomson Reuters – sold the business to Onex Corp. and Baring Private Equity Asia. The new company has since emerged as Clarivate Analytics, a name that speaks to accelerating the pace of innovation with the trusted insights and analytics it provides to customers. Read More
The curtain closed last week on the 2017 American Society of Clinical Oncology (ASCO) meeting. Like the past couple of meetings, immunotherapies received the lion's share of attention and created the most buzz, which is hardly surprising since the ability to turn cold tumors hot, either with new monotherapies or an ever-expanding number of combination therapies, is certainly a promising direction for the future of cancer research. Read More
As part of their economic development strategies, countries outside of the U.S. continue to grow their life sciences and biopharmaceutical presence, gaining on the U.S. leadership in biopharmaceutical R&D, according to a new report prepared by Teconomy Partners LLC for the Pharmaceutical Research and Manufacturers of America (PhRMA). Read More
